Antisense inhibition of the brain kallikrein-kinin system

Hypertension

Volumn 28, Issue 6, 1996, Pages 980-987

  Madeddu, Paolo ^a   Parpaglia, Paolo Pinna ^b   Glorioso, Nicola ^b   Chao, Lee ^b   Chao, Julie ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b NONE

Author keywords

brain; DNA; fluorescence; hypertension, genetic; kallikrein; kinins

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BRADYKININ; BRADYKININ B2 RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; KALLIKREIN; KININ; KININOGEN; PROTEIN;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; FLUORESCENCE; HEREDITARY HYPERTENSION; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029852346     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.980     Document Type: Article

References (43)

1. Margolius HS. Kallikrein and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension. 1995;26:221-229.
2. Clements JA. The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr Rev. 1989;10: 393-419.
3. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:1-46.
4. Chao J, Woodley C, Margolius HS. Identification of tissue kallikrein in brain and in cell-free translation product encoded by brain mRNA. J Biol Chem. 1983;258:15173-15178.
5. Simson JAV, Dom R, Chao J, Woodley C, Chao L, Margolius HS. Immunocytochemical localization of tissue kallikrein in brain ventricular epithelium and hypothalamic cell bodies. J Histochem Cytochem. 1985;33:951-953.
6. Correa FMA, Innis RB, Uhl GR, Snyder SH. Bradykinin-like immunoreactive neuronal system localized histochemically in rat brain. Proc Natl Acad Sci U S A. 1979;76:1489-1493.
7. Perry DC, Snyder SH. Identification of bradykinin in mammalian brain. J Neurochem. 1984;43:1072-1080.
8. Scicli AG, Forbes G, Nolly H, Dujovny M, Carretero OA, Kallikrein-kinins in the central nervous system. Clin Exp Hypertens A. 1984; 6:1731-1737.
9. Richoux JP, Gelly JL, Bouhnik J, Haussant T, Alhenc-Gelas F, Grignon G, Corvol P. The kallikrein-kinin system in the rat hypothalamus. Histochemistry. 1991;96:229-243.
10. 2 bradykinin receptor. Proc Natl Acad Sci U S A. 1991;88: 7724-7728.
11. Correa FMA, Graeff FG. Central mechanisms of the hypertensive action of intraventricular bradykinin in the unanesthetized rat. Neuropharmacology. 1974;13:65-75.
12. Lewis RE, Phillips MI. Localization of the central pressor action of bradykinin to the cerebral third ventricle. Am J Physiol. 1984;247: R63-R68.
13. Thomas GR, Hiley CR. Cardiovascular effects of intracerebroventricular bradykinin and melittin in the rat. J Pharm Pharmacol. 1988; 40:721-723.
14. Martins DTO, Fior DR, Nakaie CR, Lindsey CJ. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin. Br J Pharmacol. 1991;103: 1851-1856.
15. Correa FMA, Graeff FG. Central site of the hypertensive action of bradykinin. J Pharmacol Exp Ther. 1975;192:670-676.
16. Diz DI. Bradykinin and related peptides in central control of cardiovascular system. Peptides. 1985;6(suppl 2):57-64.
17. Privitera PJ, Thibodeaux H, Yates P. Rostral ventrolateral medulla as a site for the central hypertensive action of kinins. Hypertension. 1994;23:52-58.
18. Caligiorne SM, Santos RA, Campagnole-Santos MJ. Cardiovascular effects produced by bradykinin microinjection into the nucleus tractus solitarii of anesthetized rats. Brain Res. 1996;720:183-190.
19. Thomas GR, Thibodeaux H, Margolius HS, Privitera PJ. Cerebrospinal fluid kinins and cardiovascular function: effects of cerebroventricular melittin. Hypertension. 1984;6:465-505.
20. Yang XP, Carretero OA, Jacobsen G, Scicli AG. Role of endogenous brain kinins in the cardiovascular response to intracerebroventricular melittin. Hypertension. 1989;14:629-635.
21. Madeddu P, Glorioso N, Soro A, Tonolo GC, Manunta P, Troffa C, Demontis MP, Varoni MV, Anania V. Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats. Hypertension. 1990;15:407-412.
22. Kariya K, Yamauchi A. Relationship between hypertensive response and brain kinin level in the rat injected intraventricularly with glandular kallikrein. Jpn J Pharmacol. 1987;43:129-132.
23. Alvarez AL, DeLorenzi A, Santajuliana D, Finkielman S, Nahmod VE, Pirola CJ. Central bradykininergic system in normotensive and hypertensive rats. Clin Sci. 1992;82:519-523.
24. Khan IM, Miller DH, Strickland J, Margolius HS, Privitera PJ. Brain kallikrein-kinin system abnormalities in spontaneously hypertensive rats. Hypertension. 1995;25(part 1):524-530.
25. Lindsley CJ, Fujita K, Martins TO. The central pressor effect of bradykinin in normotensive and hypertensive rats. Hypertension. 1988; 11(suppl I):I-126-I-129.
26. Madeddu P, Glorioso N, Varoni MV, Demontis MP, Fattaccio MC, Anania V. Cardiovascular effects of brain kinin receptor blockade in spontaneously hypertensive rats. Hypertension. 1994;23(suppl I): I-189-I-192.
27. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature. 1994;372:333-335.
28. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarction. Nature. 1993; 363:260-263.
29. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci. 1994;15:42-46.
30. Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents: is the bullet really magical? Science. 1993;261:1004-1012.
31. Wielbo D, Sernia C, Gyurko R, Phillips MI. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension. 1995;25:314-319.
32. 1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 1993;49:167-174.
33. Furuto-Kato S, Matsumoto A, Kitamura N, Nakanishi S. Primary structures of the mRNA encoding the rat precursors for bradykinin and T-kinin. J Biol Chem. 1985;260:12054-12059.
34. 2 receptor gene. Biochim Biophys Acta. 1994;1219:171-174.
35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
36. Chao J, Swain C, Chao S, Xiong W, Chao L. Tissue distribution and kininogen gene expression after acute-phase inflammation. Biochim Biophys Acta. 1988;964:329-339.
37. Shimamoto KS, Tonaka T, Nakao T, Ando Y, Nakahashi M. Measurement of urinary kallikrein activity by kinin radioimmunoassay. Jpn Circ J. 1979;43:147-152.
38. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Increased level of bradykinin and its metabolites in tissues of young spontaneously hypertensive rats. J Hypertens. 1995;13: 739-746.
39. Madeddu P, Varoni MV, Demontis MP, Fattaccio MC, Pinna Parpaglia P, Glorioso N. A kallikrein-like enzyme in the aorta of normotensive and hypertensive rats. Hypertension. 1994;23: 899-902.
40. DePasquale MJ, Fossa AA, Holt WF, Mangiapane M. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension. 1992;19:668-671.
41. Madeddu P, Anania V, Varoni MV, Pinna Parpaglia P, Demontis MP, Fattaccio C, Palomba D, Pollock D, Glorioso N. Prevention by blockade of angiotensin subtype 1-receptors of the development of genetic hypertension but not its heritability. Br J Pharmacol. 1995;115:557-562.
42. Kawano Y, Yoshida K, Matsuoka H, Omae T. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Am J Hypertens. 1994;7:536-542.
43. 1 receptors lowers blood pressure in salt-sensitive rats. Hypertension. 1992;20:755-762.